IP Stars

Search results

Filters

Result types
Article type
Jurisdiction
Practice area
Industry sector

Showing 1 - 10 of 40 for "drugs" with applied filters

News & Analysis

EU rules on Supplementary Protection Certificates to be clarified in Halozyme CJEU case

22 June 2026 by Società Italiana Brevetti (SIB)

Società Italiana Brevetti (SIB) speak about how the EU rules on Supplementary Protection Certificates will be clarified in Halozyme CJEU case

Firm

Bird & Bird - United Arab Emirates
Firm

Husch Blackwell - United States (National)
Firm

Gulliksson - Sweden
Firm

Bird & Bird - Poland
Firm

ZBM Patents & Trademarks - Spain

Industry sectors

Aerospace & defence, Automotive, Chemistry, E-commerce, Electronics, Food & beverage, ICT & software, Life sciences, Manufacturing, Medical devices, Nanotechnology, Pharmaceutical, Renewable energy, Robotics, Semiconductors, Telecommunication, Universities & research

Firm

PI IP LAW (Lee Park & Associates) - South Korea
Firm

Reddie & Grose - United Kingdom (England)
News & Analysis

Further clarification on imminent infringement of a medicinal product in Unified Patent Court law

04 November 2024 by Società Italiana Brevetti (SIB)

Claudio Germinario points out a recent order of the UPC’s Munich Local Division as a source of guidance.
News & Analysis

Imminent infringement of a medicinal product under UPC rules: an interesting decision

10 October 2024 by Società Italiana Brevetti

Società Italiana Brevetti on patent infringement in the area of medicinal products.
Load more